SURGERY PARTNERS INC (SGRY:NASDAQ)
$13.69 -0.24 (-1.7229%)
Analysed SURGERY PARTNERS INC (SGRY:NASDAQ) News Sources
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call
17-08-2026
yahoo.com
Community Health Trades at a Deep Discount to Peers: Hold or Fold?
17-08-2026
yahoo.com
Surgery Partners (SGRY) Stock May Be Undervalued After Q2 Earnings Beat
20-08-2026
yahoo.com
3 Cash-Producing Stocks Walking a Fine Line
27-08-2026
yahoo.com
SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift
13-08-2026
yahoo.com
Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction
24-07-2026
yahoo.com
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates
10-08-2026
yahoo.com
Surgery Partners shares edge lower despite Q2 revenue beat
10-08-2026
advfn.com
Surgery Partners (SGRY) Q2 Earnings: What To Expect
11-08-2026
yahoo.com
Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript
17-08-2026
fool.com
What is the current price of SURGERY PARTNERS INC (SGRY:NASDAQ)?
The current price of SURGERY PARTNERS INC (SGRY:NASDAQ) is $13.69.
SURGERY PARTNERS INC (SGRY:NASDAQ) absolute price change since previous trading day?
The absolute price change of SURGERY PARTNERS INC (SGRY:NASDAQ) since the previous trading day is $-0.24.
SURGERY PARTNERS INC (SGRY:NASDAQ) percentage price change since previous trading day?
The percentage price change of SURGERY PARTNERS INC (SGRY:NASDAQ) since the previous trading day is -1.7229%.
What is the most recent average sentiment score for SURGERY PARTNERS INC (SGRY:NASDAQ)?
The most recent average sentiment score for SURGERY PARTNERS INC (SGRY:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for SURGERY PARTNERS INC (SGRY:NASDAQ)?
The most recent sentiment for SURGERY PARTNERS INC (SGRY:NASDAQ) is .
SEC-8K** Filing Available For SURGERY PARTNERS INC (SGRY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.